Abstract
To date, no soluble markers can discriminate benign from malignant breast lesion; therefore, to assess the diagnostic potential of circulating intercellular adhesion molecule-1 (sICAM-1), serum concentrations of sICAM-1 were quantitated in 230 consecutive patients that underwent surgery for breast neoplasias, utilizing an enzyme-linked immunosorbent assay. Histological diagnosis revealed that 177 patients had breast cancer and 53 had a benign breast disease. In the cancer patient group, 90 subjects had pTl tumors without (pT1N0M0, n=46) or with (pT1N1M0, n=41; pT1N2M0, n=3) regional lymph node metastases. Mean levels of serum sICAM-1 of patients with pT1 breast cancer, without or with regional lymph node involvement, were significantly (P<0.05) higher than those of patients with benign breast lesions and of 49 age-matched control subjects. Elevated levels of serum sICAM-1 were detected in 27/90 (30%) pTl breast tumors and in 1/53 (2%) benign breast lesions; thus, among subjects with high levels of sICAM-1, 96% had breast cancer. No significant correlation was found between levels of serum sICAM-1 and breast cancer progression. These observations, altogether, suggest that in the presence of a suspicious breast neoplasm the quantitative analysis of serum sICAM-1 can orient clinical diagnosis towards malignancy.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Elmore JG, Barton MB, Moceri VM, Polk S, Arena PJ, Fletcher SW: Ten-year risk of false positive screening mammograms and clinical breast examinations. N Engl J Med 338: 1089–1096, 1998
Schwartz GF, Schwarting R: Clinical application of tissue and serum markers in breast cancer. In: Hanausek M, Walaszek Z (eds) Methods in molecular medicine: tumor marker protocols. Humana Press INC, Totowa NJ, 1998, Vol 14, pp. 61–91
Rothlein R, Czajkowski M, O'Neill MM, Marlin SD, Mainolfi E, Merluzzi VJ: Induction of intercellular adhesion molecule-1 on primary and continuous cell lines by pro-inflammatory cytokines. J Immunol 141: 1665–1669, 1988
Smith MEF, Thomas JA: Cellular expression of lymphocyte function associated antigens and the intercellular adhesion molecule-1 in normal tissue. J Clin Pathol 43: 893–900, 1990
Maurer CA, Friess H, Kretschmann B, Wildi S, Muller C, Graber H, Schilling M: Over-expression of ICAM-1, VCAM-1 and ELAM-1 might influence tumor progression in colorectal cancer. Int J Cancer 79: 76–81, 1998
Natali PG, Hamby CV, Felding-Habermann B, Liang B, Nicotra MR, Di Filippo F, Giannarelli D, Temponi M, Ferrone S: Clinical significance of avb3 integrin and intercellular adhesion molecule-1 expression in cutaneous malignant melanoma lesions. Cancer Res 57: 1554–1560, 1997
Koyama S, Ebihara T, Fukao K: Expression of intercellular adhesion molecule 1 (ICAM-1) during the development of invasion and/or metastasis of gastric carcinoma. J Cancer Res Clin Oncol 118: 609–614, 1992
Maio M, Del Vecchio L: Expression and functional role of CD54/intercellular adhesion molecule-1 (ICAM-1) on human blood cells. Leuk Lymphoma 8: 23–33, 1992
Rothlein R, Mainolfi EA, Czajkowski M, Marlin SD: A form of circulating ICAM-1 in human serum. J Immunol 147: 3788–3793, 1991
Grothey A, Heistermann P, Philippou S, Voigtmann R: Serum levels of soluble intercellular adhesion molecule-1 (ICAM-1, CD54) in patients with non-small-cell lung cancer: correlation with histological expression of ICAM-1 and tumour stage. Br J Cancer 77: 801–807, 1998
Sprenger A, Schardt C, Rotsch M, Zehrer M, Wolf M, Havemann K, Heymanns J: Soluble intercellular adhesion molecule-1 in patients with lung cancer and benign lung diseases. J Cancer Res Clin Oncol 123: 632–638, 1997
Velikova G, Banks RE, Gearing A, Hemingway I, Forbes MA, Preston SR, Jones M, Wyatt J, Miller K, Ward U, Al-Maskatti J, Singh SM, Ambrose NS, Primrose JN, Selby PJ: Circulating soluble adhesion molecules E-cadherin, E-selectin, intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) in patients with gastric cancer. Br J Cancer 76: 1398–1404, 1997
Shimizu Y, Minemura M, Tsukishiro T, Kashii Y, Miyamoto M, Nishimori H, Higuchi K, Watanabe A: Serum concentration of intercellular adhesion molecule-1 in patients with hepatocellular carcinoma is a marker of the disease progression and prognosis. Hepatology 22: 525–531, 1995
Altomonte M, Colizzi F, Esposito G, Maio M: Circulating intercellular adhesion molecule 1 as a marker of disease progression in cutaneous melanoma. N Engi J Med 327: 959, 1992
Sheen-Chen S-M, Eng H-L, Sheen C-W, Cheng Y-F, Chou FF, Chen W-J: Serum levels of circulating intercellular adhesion molecule-1 in patients with breast cancer. Anticancer Res 17: 2823–2826, 1997
Levin I, Klein T, Shapira Y, Lurie H, Kfir HLB, Narinsky R, Lehmann JM, Klein B: Serum intracellular adhesion molecule 1 (sICAM-1) and soluble HLA class 1 antigens in breast cancer patients in relation to tumor burden. Oncol Rep 1: 217–220, 1994
Budinsky AC, Brodowicz T, Wiltschke C, Czerwenka K, Michl I, Krainer M, Zielinski CC: Decreased expression of ICAM-1 and its induction by tumor necrosis factor on breastcancer cells in vitro. Int J Cancer 71: 1086–1090, 1997
Ogawa Y, Hirakawa K, Nakata B, Fujihara T, Sawada T, Kato Y, Yoshikawa K, Sowa M: Expression of Intercellular Adhesion Molecule-1 in invasive breast cancer reflects low growth potential, negative lymph node involvement, and good prognosis. Clin Cancer Res 4: 31–36, 1998
Fox SB, Turner GDH, Leek RD, Whitehouse RM, Gatter KC, Harris AL: The prognostic value of quantitative angiogenesis in breast cancer and role of adhesion molecule expression in tumor endothelium. Breast Cancer Res Treat 36: 219–226, 1995
Heffelfinger SC, Yassin R, Miller MA, Lower E: Vascularity of proliferative breast disease and carcinoma in situ correlates with histological features. Clin Cancer Res 2: 1873–1878, 1996
Fonsatti E, Altomonte M, Coral S, Cattarossi I, Nicotra MR, Gasparollo A, Natali PG, Maio M: Tumor-derived interleukin 1a (IL-1a) up-regulates the release of soluble intercellular adhesion molecule-1 (sICAM-1) by endothelial cells. Br J Cancer 76: 1255–1261, 1997
Fonsatti E, Lamaj E, Coral S, Sigalotti L, Nardi G, Gasparollo A, Colombo MP, Altomonte M, Maio M: In vitro analysis of the melanoma- endothelium interaction increasing the release of soluble ICAM-1 by endothelial cells. Cancer Immunol Immunother 48: 132–138, 1999
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Altomonte, M., Fonsatti, E., Lamaj, E. et al. Differential levels of soluble intercellular adhesion molecule-1 (sICAM-1) in early breast cancer and benign breast lesions. Breast Cancer Res Treat 58, 19–23 (1999). https://doi.org/10.1023/A:1006280729252
Issue Date:
DOI: https://doi.org/10.1023/A:1006280729252